Skip to main content

Atle Fund Management AB

Source: SEC Form 13F · as of Mar 2026

Atle Fund Management AB holds 30 biotech & pharma companies tracked by BioSniper, totaling $235.8M in value as of Mar 2026 (SEC Form 13F).

Companies held

30

Total value held

$235.8M

BioSniper AIPage evidence connected

Prepared research question

What matters most for ELI LILLY & Co (LLY)—catalysts, financial risk and supporting evidence?

Run cited research

Traceable citations · Unknowns marked

CompanySharesValue
LLYELI LILLY & Co39,722$26.8M
MRKMerck & Co., Inc.33,853$22.9M
ONCBeOne Medicines Ltd.41,717$12.1M
JNJJOHNSON & JOHNSON92,377$11.9M
BBIOBridgeBio Pharma, Inc.111,363$11.9M
VRTXVERTEX PHARMACEUTICALS INC / MA22,984$11.2M
ABBVAbbVie Inc.108,181$10.4M
IONSIONIS PHARMACEUTICALS INC27,873$9.4M
MIRMMirum Pharmaceuticals, Inc.195,768$9.4M
RVMDREVOLUTION MEDICINES, INC.617,245$9.1M
AMGNAMGEN INC21,903$8.7M
ALKSAlkermes plc.242,473$8.2M
INCYIncyte Corp.50,796$8.0M
NBIXNEUROCRINE BIOSCIENCES INC89,685$7.9M
GILDGILEAD SCIENCES, INC.47,967$7.2M
KRYSKrystal Biotech, Inc.37,579$6.8M
CORCencora Inc.23,470$6.6M
INSMINSMED Inc97,438$6.0M
NAMSNEWAMSTERDAM PHARMA CO N.V.94,796$5.5M
ABVXAbivax SA31,590$4.8M
CAHCardinal Health Inc.108,682$4.8M
IDYAIDEAYA Biosciences, Inc.31,133$4.0M
TNGXTango Therapeutics, Inc.29,915$3.6M
SYRESpyre Therapeutics, Inc.62,735$3.5M
IRONDisc Medicine, Inc.107,255$3.2M
CMPXCompass Therapeutics, Inc.41,831$3.1M
UNHUnitedHealth Group Incorporated Common Stock (DE)14,636$2.8M
BCAXBicara Therapeutics Inc.1,169,634$2.3M
SLNOSOLENO THERAPEUTICS INC90,184$2.2M
PYXSPyxis Oncology, Inc.197,036$1.6M

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.